Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies

doi:10.4251/wjgo.v7.i11.338

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8215)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

642

WORD

251

HTML

4547

Tables (1-3)

340

Sum=5780

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1019

Download

1416

Sum=2435

Nov 15, 2015 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Nov 15, 2015; 7(11): 338-346
Published online Nov 15, 2015. doi: 10.4251/wjgo.v7.i11.338

Table 3 Ongoing clinical trials of immunotherapy in biliary tract carcinoma

Agent	Treatment regimen	Phase	Estimated date of completion	Sponsoring Institution	Identification number
Cytokine induced killer cells	Cytokine induced killer cell monotherapy	I/II	May, 2016	Siriraj Hospital	NCT01868490
Tumor infiltrating lymphocytes	Tumor infiltrating lymphocytes + IL-2 + cyclophosphamide + fludarabine	II	December, 2019	National Cancer Institute	NCT01174121
Poly-ICLC	Cyclophosphamide + radiation therapy + TACE + poly-ICLC	I/II	July, 2014	Rutgers, the State University of New Jersey	NCT00553683

IL-2: Interleukin-2; Poly-ICLC: Polyinosinic-polycytidylic acid polylysine carboxymethylcellulose; TACE: Transcatheter arterial chemoembolization.

Citation: Marks EI, Yee NS. Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies. World J Gastrointest Oncol 2015; 7(11): 338-346
URL: https://www.wjgnet.com/1948-5204/full/v7/i11/338.htm
DOI: https://dx.doi.org/10.4251/wjgo.v7.i11.338